Markup Madness

MARKUP MADNESS

Who’s Profiting
fromYour
Prescription?

MARKUP MADNESS

Who’s Profiting
from Your
Prescription?

MARKUP MADNESS

Who’s Profiting
from Your
Prescription?

Middlemen Are Marking Up Your GenericsTake a look at the list of commonly prescribed generic medicines below and note the gap between what generic drug makers charge for their medicines (to others in the supply chain) and what patients might pay if they chose to only use just cash when filling their prescription at the pharmacy.
PreviousNext
Unlike brand drugs where the manufacturer stands to profit the most, generic medicines are often exploited by middlemen that seize significant profits at the expense of patients and the companies that make the medicines.
For example:

Atorvastatin

Atorvastatin, the generic medicine for Lipitor commonly prescribed to control high cholesterol, sells to patients at retail for $46 cash. Generic drug makers sell it to their customers in the supply chain for only $1.46.

Omeprazole

Omeprazole, the prescription generic medicine for Prilosec commonly prescribed to prevent heartburn and stomach ulcers, sells to patients at retail for $74 cash. Generic drug makers sell it to their customers in the supply chain for only $0.92.
Source: IQVIA, US Market Access Strategy Consulting Analysis, January 18, 2022. Dollar amount is reflective of a 30-day supply.
Generic drug makers are not to blame for high out-of-pocket costs for patients.

Policymakers can address these challenges and ensure the sustainability of the generic and the emerging biosimilar medicines markets. The AAM Roadmap For Ensuring Patient Access has key steps policymakers can take to ensure all Americans continue to benefit from a competitive and robust generics and biosimilars industry.

Modernize Medicare Part D – The Medicare Part D benefit should be modernized to address the perverse incentives that currently favor high-cost brand name drugs over lower-cost generic and biosimilar medicines.

Reduce Medicare Cost Sharing for Seniors – The Ensuring Access to Lower-Cost Medicines for Seniors Act would ensure coverage of newly available generic and biosimilar medicines, reduce patient cost-sharing through proper formulary tier coverage and create a new specialty tier for biosimilars.

Eliminate the Medicaid Generics Penalty – The Protecting Access to Affordable Medicines Act would fix the misguided application of the Medicaid rebate on generic medicines, reducing the risk of drug shortages and benefiting patients through sustainable access to low-cost generics.

Address Patent Abuse – The Restoring the America Invents Act would strengthen the Inter-Partes Review process to support earlier generic entry.

Preserve the Tools that Drive Competition and Savings – Developers of generic and biosimilar medicines rely on the 180-day exclusivity period for new generics and the ability to accelerate competition through patent settlements and the “skinny label” pathway.
View AAM RoadmapView Supply Chain

Resources and Media

Download the Social Toolkit Here

Press Release

AAM Calls on FTC to Investigate PBM Business Practices

Public Letter

Generic Manufacturers Ask the DOJ and the FTC to Investigate Market Abuses by Buying Groups

AAM Blog

Seniors Are Still Missing Out on Savings in Medicare Part D

AAM Blog

Generic Prices Are Falling, But Seniors Are Paying More for Generic Drugs. What’s Happening Here?

Report

2021 U.S. Generic and Biosimilar Medicines Savings Report

Report

Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution

Report

Access Denied: Why New Generics Are Not Reaching America’s Seniors

Report

AAM Securing Sustainable Markets

Campaign

Abuse of the patent system is keeping drug prices high for patients

AAM Blog

The Medicaid Generics Penalty: A Primer

Report

Medicare and Commercial Plans Fail to Get New Generics to Patients

Press Release

Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays

RAPS

AAM: Medicare Part D plans slow to adopt generics

AAM Blog

The First (Price) Cut Is the Steepest

Follow the Movement

Middlemen profit-taking threatens sustained patient savings and access to generic medicines. That is #MarkupMadness! Learn more

TAGS:Who Markup Madness Your

<<< Thank you for your visit >>>

Websites to related :
Pineland Telephone Cooperative &

　　AboutOur HistoryPineland DirectorsTestimonialsDisclosuresServicesPhoneInternetTVSecurityApplyNewsPress ReleasesNewsletterFRS Youth TourFRS Scholarship

Your Invitation Awaits You~Evolv

　　About/Contact UsAdvertiseSpecial Advertising Audio Commercial BundlesNewsletter &#038; GiveawaysBooks We AdoreAudiobook ProductionAuthor Audio Commerc

Enjoy St Albans - Choose your st

　　 Things to doShoppingEat &#038; DrinkWhat&#8217;s onWhere to StayOffersTravelMaps &#038; GuidesBlog Things to doShoppin

Keep your dependencies up-to-dat

　　Deps.rsKeep your dependencies up-to-dateDeps.rs uses semantic versioning to detect outdated or insecure dependencies in your project'sCargo.toml.Popul

Jazz.wien - get your daily do

　　HomeKonzerteÜber unsSucheKontaktWeitere Konzerteweitere Konzerte anzeigenpowered by JazzFest.Wien© Jazz.wien 2016-22 • info@jazz.wien • ImpressumD

VidLii - Display Yourself

　　首頁影片頻道社區註冊幫助登錄上傳Videos Being Watched Now4:41how to make a virus or app19 viewsPenguinchaos6:31Leopold Trylogia 221 viewsPiratiker4471:

Antgrip - Make your gaming mouse

　　 ShopAsus ROGCooler MasterGloriousG-WolvesLogitech GNaconRazerRedragonRoccatSteelseriesZowieShippingFAQBlogCartMy accountCheckout ShopAsus ROGCoole

SiteTenders - Protect Your Legac

　　HomeHow It WorksPricing & FAQGet StartedLoginLife happens. Protect your personal|family|hobby|research|work legacy.You've developed your website. It'

Take the CogitoHub Career Test t

　　

Introstyle Premium - Wholesale s

　　PhilosophyCampaignCatalogAbout usOur TeamBenefitsBecome a partnerContact usWholesale supplier of Women's Clothing
international deliveryOur Philosoph

ads

Hot Websites